≡ Sucampo & Takeda Enter New Drug Agreement, Lubiprostone, for Chronic Constipation & IBS Part 2
“This help and license agreement be a focal milestone all for Sucampo,” said President and CEO, Sachiko Kuno, PhD. “We be greatly incited with this strategic alliance near Takeda, which already developed an untouchable reputation contained by its flair to puff market-leading stuff in the U.S., and the synergies that will knock-on effect […]
